Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992947 | SCV001145564 | uncertain significance | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | |
Paris Brain Institute, |
RCV001391614 | SCV001451174 | pathogenic | Amyotrophic lateral sclerosis type 4 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000992947 | SCV001962580 | pathogenic | not provided | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000992947 | SCV002759048 | likely pathogenic | not provided | 2022-11-27 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate this variant results in impaired RNA binding, and consequently impaired duplex unwinding and in vitro transcription termination (Leonaite et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19696032, 23129421, 25116135, 31069529, 35936600, 28408439, 31429931, 31656689) |